These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23796476)

  • 1. Reply to: "Flow cytometry makes all the difference".
    Oliviero B; Mele D; Varchetta S; Mondelli MU
    J Hepatol; 2013 Oct; 59(4):910-1. PubMed ID: 23796476
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow cytometry makes all the difference.
    Pembroke T; Gallimore A; Godkin A
    J Hepatol; 2013 Oct; 59(4):909-10. PubMed ID: 23792877
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological changes in different patient populations with chronic hepatitis C virus infection.
    Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
    World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mission poorly accomplished: the protective role of natural killer cells in recurrent hepatitis C after liver transplantation.
    Zein NN
    Liver Transpl; 2008 Jan; 14(1):4-6. PubMed ID: 18161796
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural killer cells in viral hepatitis: facts and controversies.
    Mondelli MU; Varchetta S; Oliviero B
    Eur J Clin Invest; 2010 Sep; 40(9):851-63. PubMed ID: 20597961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.
    Nattermann J; Feldmann G; Ahlenstiel G; Langhans B; Sauerbruch T; Spengler U
    Gut; 2006 Jun; 55(6):869-77. PubMed ID: 16322112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytotoxic activity of natural killer cells in children with chronic type C hepatitis].
    Woźniakowska-Gesicka T; Wiśniewska-Ligier M; Pokoca L; Kupś J
    Pol Merkur Lekarski; 2003 May; 14(83):428-30. PubMed ID: 12939819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
    Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
    Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells and hepatitis C: action and reaction.
    Cheent K; Khakoo SI
    Gut; 2011 Feb; 60(2):268-78. PubMed ID: 20876777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Involvement of dendritic cell dysfunction in the persistence of hepatitis C virus infection].
    Kanto T; Hayashi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):170-4. PubMed ID: 15359787
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered innate immunity in chronic hepatitis C infection: cause or effect?
    Szabo G; Chang S; Dolganiuc A
    Hepatology; 2007 Oct; 46(4):1279-90. PubMed ID: 17886338
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic hepatitis C: virologic and immunologic aspects].
    Moriya K; Koike K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):405-7. PubMed ID: 15359831
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural killer cells in hepatitis C: Current progress.
    Yoon JC; Yang CM; Song Y; Lee JM
    World J Gastroenterol; 2016 Jan; 22(4):1449-60. PubMed ID: 26819513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do direct acting antivirals cure chronic hepatitis C?
    Jakobsen JC; Nielsen EE; Koretz RL; Gluud C
    BMJ; 2018 May; 361():k1382. PubMed ID: 29748173
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
    Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
    Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intrahepatic and peripheral blood lymphocytes during hepatitis C].
    Tomasiewicz K; Modrzewska R
    Przegl Epidemiol; 2006; 60(4):665-72. PubMed ID: 17682746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
    Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H
    Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of peripheral blood natural killer cells, T-cell helper/T-cell suppressor ratio and intercurrent infection frequency in hepatitis C seropositive prevalent hemodialysis patients.
    Ibrahim MA; Mostafa AA; El-Said HW; Mohab AM; Hebah HA
    Hemodial Int; 2014 Oct; 18 Suppl 1():S23-31. PubMed ID: 25330828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.
    Cheng YQ; Ren JP; Zhao J; Wang JM; Zhou Y; Li GY; Moorman JP; Yao ZQ
    Immunology; 2015 Aug; 145(4):485-97. PubMed ID: 25772938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD56 negative NK cells: origin, function, and role in chronic viral disease.
    Björkström NK; Ljunggren HG; Sandberg JK
    Trends Immunol; 2010 Nov; 31(11):401-6. PubMed ID: 20829113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.